Peter S. Ang
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.
Journal: NPJ breast cancer
Published: December 03, 2025
Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients.
Journal: Clinical epigenetics
Published: December 11, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Journal: Human genomics
Published: May 10, 2023
Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody-drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore.
Journal: Expert opinion on drug metabolism & toxicology
Published: January 13, 2023
Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility.
Journal: Human genomics
Published: December 19, 2022
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations.
Journal: Clinical pharmacology and therapeutics
Published: October 28, 2022
Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility.
Journal: Human genomics
Published: August 15, 2022
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens.
Journal: Breast cancer research and treatment
Published: April 08, 2021
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.
Journal: Breast cancer research and treatment
Published: December 23, 2020
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 17, 2019
Last Updated: 09/26/2026